ENDO 2006 Media-Specifc Activities are bolded below. Please contact media@endo-society.org with any questions.

Saturday, June 24, 2006

8:00 A.M. – 9:15 A.M. – Women’s Health Initiative - Hormone Therapy Trial: Timing is Everything (Presidential Plenary)

10:00 A.M. – 11:00 A.M. – Clinical Practice Guidelines Media Roundtable

• Robert A. Vigersky, M.D., Chair of The Endocrine Society’s Clinical Guidelines Subcommittee
• Mark E. Molitch, M.D., Chair of the Adult Growth Hormone Deficiency Guidelines Task Force, “Evaluation and Treatment of Adult Growth Hormone Deficiency.”
• Shalender Bhasin, M.D., Chair of the Androgen Deficiency in Men Guidelines Task Force, “Testosterone Therapy in Adult Men with Androgen Deficiency Syndromes.”

3:30 P.M. – 5:00 P.M. – Neuroendocrine Consequences of Stress (Basic Symposia)

3:30 P.M. – 5:00 P.M. – Polycystic Ovary Syndrome: Birth to Adulthood (Clinical Symposia)

5:30 P.M. – 6:00 P.M. – Media Panel with Corporate Liaison Board Forum Presenters (Metabolic Syndrome debate)

• Andres Negro-Vilar, M.D., Ph.D., Chair of the Corporate Liaison Board
• Robert Eckel, M.D., University of Colorado at Denver and Health Science Center, President, American Heart Association
• John Buse, M.D., Ph.D., University of North Carolina School of Medicine, Diabetes Care Center, Vice President, American Diabetes Association
• Richard Heyman, Ph.D., Spokesperson for pharmaceutical industry, Exelixis, Inc.

6:30 P.M. - 9:30 P.M. –Corporate Liaison Board Forum - Controversies in Endocrinology: Impact and Management of the Metabolic Syndrome Agenda Introductory Remarks: The Challenge of Metabolic Syndrome,

• Andres Negro-Vilar, M.D., Ph.D., Chair, Corporate Liaison Board Treatment of Metabolic Syndrome: A Regulatory Perspective,
• K. Eddie Gabry, M.D., M.S., F.A.C.E., Food & Drug Administration, Center for Drug Evaluation and Research Metabolic Syndrome: Important Predictor, Need for Intervention?
• Arguing in favor: Robert Eckel, M.D., University of Colorado at Denver and Health Science Center
• Arguing against: John Buse, M.D., Ph.D., University of North Carolina School of Medicine, Diabetes Care Center Treatment Targets for Metabolic Syndrome: An Industry Perspective,
• Richard Heyman, Ph.D., Exelixis, Inc.
•  

Sunday, June 25, 2006

9:00 A.M. – 10:00 A.M. - Pediatric Health Breaking Research Press Conference

• Abstract # 2145 - Components of healthcare products associated with male prepubertal gynecomastia possess estrogenic and antiandrogenic activities ·
• Abstract # 2032 – Earlier mother’s age at menarche predicts rapid infant growth and childhood obesity
• Abstract # 942 – Insulin pump therapy in very young children
• Abstract # 2327 – Pediatric Type 2 diabetes: Current evaluation and treatment patterns in the U.S.

9:30 A.M. – 11:00 A.M. – Controversies in Endocrinology: Controversies in Endocrine Replacement Therapy (Clinical Symposia)

9:30 A.M. – 11:00 A.M. – Bone Disease in the Young: Etiology and Treatment (Clinical Symposia)

9:30 A.M. – 11:00 A.M. – Growth Hormone: Pediatric (Clinical Symposia)

11:10 A.M – 12:30 P.M. – Is There a Role for Androgen Replacement Therapy for Hypogonadism of Aging Men? (ENDO Debate)

1:30 P.M. – 2:30 P.M. - Androgen Assays Working Group/Androgens & Women

Androgen Assays Experts:

1. William Rosner, M.D. Columbia University
2. Patrick M. Sluss, Ph.D. Harvard University

Androgens in Women Experts:

1. Margaret E. Wierman, M.D. University of Colorado Health Sciences Center
2. Susan R. Davis, M.B.B.S., M.D., F.R.A.C.P., Ph.D. Monash University

3:30 P.M. – 5:00 P.M. – The Endocannabinoid System (Translational Symposia)

Monday, June 26, 2006

8:30 A.M. – 10:00 A.M. – The Hormone Foundation Media Roundtable, Sponsored by Wyeth Pharmaceuticals & Eli Lilly

• Judy Foreman – Moderator, The Boston Globe
• Robert B. Jaffe, M.S., M.D. – The Hormone Foundation
• Richard J. Santen, M.D. – Breast Cancer expert
• JoAnn E. Manson, M.D., Ph.D. – Principal Investigator, Women’s Health Initiative

9:30 A.M. – 11:00 A.M. – Obesity (Clinical Symposia)

12:00 P.M. – 12:50 P.M. - NIH at the Crossroads: Myths, Realities and Strategies for the Future – Elias Zerhouni, M.D., Director National Institutes of Health

1:00 P.M. – 2:00 P.M. – Androgens & Women Breaking Research Press Conference 

• Abstract # 2250- Higher testosterone levels predict cardiovascular disease in older women
• Abstract # 225 –Testosterone administration improves mood, sexual function and quality of life but not cognitive function in women with hypopituitarism
• Abstract # 390 – Biocompatible hydrogel rings to deliver non-hormonal, contraceptive agents

3:30 P.M. – 5:00 P.M. – Metabolic Syndrome & Growth Factor Signaling: Factors that Influence Susceptibility for the Metabolic Syndrome (Clinical Symposia)

3:30 P.M. – 5:00 P.M. – Growth Hormone Deficiency in Adults (Clinical Symposia)

Tuesday, June 27, 2006

8:00 A.M. – 9:15 A.M. – Embryonic and Neural Stem Cells: Potential for Spinal Cord Repair & Other Disease States (Plenary Lecture)

9:30 A.M. – 11:00 A.M. – Stem Cells & Transplantation: Embryonic & Adult Stem Cell Biology (Basic Symposia)

9:30 A.M. – 11:00 A.M. – Age-dependent Outcomes of Thyroid Dysfunction (Clinical Symposia)

11:00 A.M. – 12:00 P.M. – Obesity Breaking Research Press Conference

• Abstract # 1148 – Vitamin D Deficiency is associated with the Metabolic Syndrome in morbidly obese patients
• Abstract # 1403 – Prevalence of non-alcoholic steatohepatitis (NASH) in patients with Type 2 diabetes mellitus
• Abstract # 1035 – Combination of Western lifestyle with recurrent sleep restriction leads to increased insulin resistance

2:00 P.M. – 3:00 P.M. – Bone Health Breaking Research Press Conference

• Abstract # 605 - Plasma homocysteine and risk of hip fracture among postmenopausal women in the Women’s Health Initiative
• Abstract # 2230 - Growth Hormone administration improves parathyroid hormone sensitivity and bone mineral metabolism in established osteoporosis
• Abstract # 1540 - Synergistic induction of osteoblastic local glucocorticoid metabolism by inflammation and glucocorticoids: A novel mechanism for glucocorticoid-induced bone disease

3:00 P.M. – 4:30 P.M. – Genetic Candidates for the Metabolic Syndrome (Basic Symposia)

3:30 P.M. – 4:30 P.M. – Androgen Replacement in Women (Clinical Symposia)

3:30 P.M. – 4:30 P.M. – Endocrine & Performance-Enhancing Drugs (Clinical Symposia)

3:30 P.M. – 4:30 P.M. – Lifestyle & Longevity (Clinical Symposia)

# # #

Founded in 1916, The Endocrine Society is the world's oldest, largest, and most active organization devoted to research on hormones and the clinical practice of endocrinology. Today, The Endocrine Society's membership consists of over 14,000 scientists, physicians, educators, nurses and students in more than 80 countries. Together, these members represent all basic, applied, and clinical interests in endocrinology. The Endocrine Society is based in Chevy Chase, Md. To learn more about the Society, and the field of endocrinology, visit our web site at www.endo-society.org.